{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T09:47:08Z","timestamp":1776505628441,"version":"3.51.2"},"reference-count":37,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Marine Drugs"],"abstract":"<jats:p>Pharmaceutical approaches based on nanotechnologies and the development of eye drops composed of the mucoadhesive polymers chitosan and hyaluronic acid are emerging strategies for the efficient treatment of ocular diseases. These innovative nanoparticulate systems aim to increase drugs\u2019 bioavailability at the ocular surface. For the successful development of these systems, the evaluation of mucoahesiveness (the interaction between the ocular delivery system and mucins present on the eye) is of utmost importance. In this context, the aim of the present work was to investigate the mucoadhesivity of a novel nanoparticle eye drop formulation containing an antibiotic (ceftazidime) intended to treat eye infections. Eye drop formulations comprised a polymer (hydroxypropyl) methyl cellulose (HPMC) 0.75% (w\/v) in an isotonic solution incorporating chitosan\/sodium tripolyphosphate (TPP)-hyaluronic acid-based nanoparticles containing ceftazidime. The viscosity of the nanoparticles, and the gels incorporating the nanoparticles were characterized in contact with mucin at different mass ratios, allowing the calculation of the rheological synergism parameter (\u2206\u03b7). Results showed that at different nanoparticle eye formulation:mucin weight ratios, a minimum in viscosity occurred which resulted in a negative rheological synergism. Additionally, the results highlighted the mucoadhesivity of the novel ocular formulation and its ability to interact with the ocular surface, thus increasing the drug residence time in the eye. Moreover, the in vitro release and permeation studies showed a prolonged drug release profile from the chitosan\/TPP-hyaluronic acid nanoparticles gel formulation. Furthermore, the gel formulations were not cytotoxic on ARPE-19 and HEK293T cell lines, evaluated by the metabolic and membrane integrity tests. The formulation was stable and the drug active, as shown by microbiological studies. In conclusion, chitosan\/TPP-hyaluronic acid nanoparticle eye drop formulations are a promising platform for ocular drug delivery with enhanced mucoadhesive properties.<\/jats:p>","DOI":"10.3390\/md15120370","type":"journal-article","created":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T12:30:16Z","timestamp":1512131416000},"page":"370","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":234,"title":["Chitosan Nanoparticles as a Mucoadhesive Drug Delivery System for Ocular Administration"],"prefix":"10.3390","volume":"15","author":[{"given":"Mariana","family":"Silva","sequence":"first","affiliation":[{"name":"Research Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, 1649-003 Lisbon, Portugal"}]},{"given":"Raquel","family":"Calado","sequence":"additional","affiliation":[{"name":"Research Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, 1649-003 Lisbon, Portugal"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5523-5622","authenticated-orcid":false,"given":"Joana","family":"Marto","sequence":"additional","affiliation":[{"name":"Research Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, 1649-003 Lisbon, Portugal"},{"name":"Laborat\u00f3rio Edol, Produtos Farmac\u00eauticos S.A., 2795-225 Linda-a-Velha, Portugal"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8498-5892","authenticated-orcid":false,"given":"Ana","family":"Bettencourt","sequence":"additional","affiliation":[{"name":"Research Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, 1649-003 Lisbon, Portugal"}]},{"given":"Ant\u00f3nio","family":"Almeida","sequence":"additional","affiliation":[{"name":"Research Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, 1649-003 Lisbon, Portugal"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6799-2740","authenticated-orcid":false,"given":"L\u00eddia","family":"Gon\u00e7alves","sequence":"additional","affiliation":[{"name":"Research Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, 1649-003 Lisbon, Portugal"}]}],"member":"1968","published-online":{"date-parts":[[2017,12,1]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.preteyeres.2010.08.002","article-title":"Applications of nanoparticles in ophthalmology","volume":"29","author":"Diebold","year":"2010","journal-title":"Prog. Retin. Eye Res."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1517\/17425240902762818","article-title":"Chitosan nanoparticles for drug delivery to the eye","volume":"6","author":"Paolicelli","year":"2009","journal-title":"Expert Opin. Drug Deliv."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"73","DOI":"10.4103\/0976-0105.118810","article-title":"Optimization of liposomal encapsulation for ceftazidime for developing a potential eye drop formulation","volume":"4","author":"Wijesooriya","year":"2013","journal-title":"J. Basic Clin. Pharm."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.jconrel.2011.04.019","article-title":"A method for enhancing the ocular penetration of eye drops using nanoparticles of hydrolyzable dye","volume":"153","author":"Baba","year":"2011","journal-title":"J. Control. Release"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1023\/B:PHAM.0000026432.75781.cb","article-title":"Chitosan Nanoparticles as New Ocular Drug Delivery Systems: In Vitro Stability, In Vivo Fate, and Cellular Toxicity","volume":"21","author":"Diebold","year":"2004","journal-title":"Pharm. Res."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1007\/s11095-008-9694-0","article-title":"Recent Perspectives in Ocular Drug Delivery","volume":"26","author":"Gaudana","year":"2009","journal-title":"Pharm. Res."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S1569-2590(05)10012-3","article-title":"Drug Delivery to the eye","volume":"Volume 10","author":"Mitra","year":"2005","journal-title":"Advances in Organ Biology"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.3109\/03639045.2012.736515","article-title":"Recent advances in ocular drug delivery","volume":"39","author":"Achouri","year":"2013","journal-title":"Drug Dev. Ind. Pharm."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S1350-9462(97)00002-5","article-title":"Ophthalmic drug delivery systems\u2014Recent advances","volume":"17","author":"Acar","year":"1998","journal-title":"Prog. Retin. Eye Res."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.ijpharm.2007.04.013","article-title":"Gels and liposomes in optimized ocular drug delivery: Studies on ciprofloxacin formulations","volume":"343","author":"Budai","year":"2007","journal-title":"Int. J. Pharm."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1016\/j.addr.2006.07.027","article-title":"Challenges and obstacles of ocular pharmacokinetics and drug delivery","volume":"58","author":"Urtti","year":"2006","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/0378-5173(92)90353-4","article-title":"In vitro evaluation of mucoadhesive properties of chitosan and some other natural polymers","volume":"78","author":"Lehr","year":"1992","journal-title":"Int. J. Pharm."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1016\/j.addr.2005.07.005","article-title":"The use of mucoadhesive polymers in ocular drug delivery","volume":"57","author":"Ludwig","year":"2005","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"278","DOI":"10.18433\/J3DP43","article-title":"Applications of polymeric and lipid nanoparticles in ophthalmic pharmaceutical formulations: Present and future considerations","volume":"17","author":"Almeida","year":"2014","journal-title":"J. Pharm. Pharm. Sci."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.addr.2009.11.026","article-title":"Chitosan-based nanostructures: A delivery platform for ocular therapeutics","volume":"62","author":"Paolicelli","year":"2010","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1002\/mabi.200700190","article-title":"Novel hyaluronan-based nanocarriers for transmucosal delivery of macromolecules","volume":"8","author":"Seijo","year":"2008","journal-title":"Macromol. Biosci."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1097\/ICO.0b013e3181bd9eee","article-title":"Ocular tolerance to a topical formulation of hyaluronic acid and chitosan-based nanoparticles","volume":"29","author":"Seijo","year":"2010","journal-title":"Cornea"},{"key":"ref_18","unstructured":"Troy, D.B. (2006). The Science and Practice of Pharmacy, Lippincott Williams & Wilkins. [21st ed.]."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Pignatello, R. (2011). Polysaccharides as Excipients for Ocular Topical Formulations. Biomaterials Applications for Nanomedicine, In Tech.","DOI":"10.5772\/1957"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.drudis.2013.10.001","article-title":"In situ gelling systems: A strategy to improve the bioavailability of ophthalmic pharmaceutical formulations","volume":"19","author":"Almeida","year":"2014","journal-title":"Drug Discov. Today"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0928-0987(00)00065-8","article-title":"Characterization of chitosan hydrochloride-mucin interaction by means of viscosimetric and turbidimetric measurements","volume":"10","author":"Rossi","year":"2000","journal-title":"Eur. J. Pharm. Sci."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1023\/A:1015812615635","article-title":"A simple rheological method for the in vitro assessment of mucin-polymer bioadhesive bond strength","volume":"7","author":"Hassan","year":"1990","journal-title":"Pharm. Res."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"885","DOI":"10.3109\/10717544.2013.858195","article-title":"Chitosan nanoparticles for daptomycin delivery in ocular treatment of bacterial endophthalmitis","volume":"22","author":"Silva","year":"2013","journal-title":"Drug Deliv."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1007\/s11095-009-9908-0","article-title":"Chitosan\/TPP and Chitosan\/TPP-hyaluronic Acid Nanoparticles: Systematic Optimisation of the Preparative Process and Preliminary Biological Evaluation","volume":"26","author":"Nasti","year":"2009","journal-title":"Pharm. Res."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.ijpharm.2011.04.031","article-title":"Chitosan\/sulfobutylether-\u03b2-cyclodextrin nanoparticles as a potential approach for ocular drug delivery","volume":"413","author":"Mahmoud","year":"2011","journal-title":"Int. J. Pharm."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.3390\/ma3021420","article-title":"Self-assembled hydrogel nanoparticles for drug delivery applications","volume":"3","author":"Pereira","year":"2010","journal-title":"Materials"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1016\/j.ijbiomac.2014.10.039","article-title":"Hyaluronic acid\/chitosan nanoparticles for delivery of curcuminoid and its in vitro evaluation in glioma cells","volume":"72","author":"Yang","year":"2015","journal-title":"Int. J. Biol. Macromol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.ejpb.2015.01.026","article-title":"Biopharmaceutical profile of pranoprofen-loaded PLGA nanoparticles containing hydrogels for ocular administration","volume":"95","author":"Abrego","year":"2015","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/S0928-0987(00)00194-9","article-title":"Characterization of chitosan hydrochloride\u2014Mucin rheological interaction: Influence of polymer concentration and polymer: Mucin weight ratio","volume":"12","author":"Rossi","year":"2001","journal-title":"Eur. J. Pharm. Sci."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.ijpharm.2007.12.001","article-title":"Evaluation of mucoadhesiveness of polymers by BIACORE method and mucin-particle method","volume":"354","author":"Thongborisute","year":"2008","journal-title":"Int. J. Pharm."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1007\/s11095-012-0761-1","article-title":"Interfacial interaction between transmembrane ocular mucins and adhesive polymers and dendrimers analyzed by surface plasmon resonance","volume":"29","author":"Noiray","year":"2012","journal-title":"Pharm. Res."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.ejps.2011.09.018","article-title":"Development and characterization of a new plasmid delivery system based on chitosan-sodium deoxycholate nanoparticles","volume":"45","author":"Cadete","year":"2012","journal-title":"Eur. J. Pharm. Sci."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.ymeth.2007.01.006","article-title":"Microtitre plate-based antibacterial assay incorporating resazurin as an indicator of cell growth and its application in the in vitro antibacterial screening of phytochemicals","volume":"42","author":"Sarker","year":"2007","journal-title":"Methods"},{"key":"ref_34","unstructured":"Cockerill, F.R., Wikler, M.A., Alder, J., Dudley, M.N., Eliopoulos, G.M., Ferraro, M.J., Hardy, D.J., Hecht, D., Hindler, J., and Patel, J. (2012). Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically; Approved Standard, Clinical and Laboratory Standards Institute. [9th ed.]."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.ijpharm.2015.11.050","article-title":"Rifabutin-loaded solid lipid nanoparticles for inhaled antitubercular therapy: Physicochemical and in vitro studies","volume":"497","author":"Gaspar","year":"2016","journal-title":"Int. J. Pharm."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.toxlet.2017.05.017","article-title":"Toxicity screening of a novel poly(methylmethacrylate)-Eudragit nanocarrier on L929 fibroblasts","volume":"276","author":"Louro","year":"2017","journal-title":"Toxicol. Lett."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.3109\/10717544.2015.1128496","article-title":"Melatonin-based Pickering emulsion for skin\u2019s photoprotection","volume":"23","author":"Marto","year":"2016","journal-title":"Drug Deliv."}],"container-title":["Marine Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1660-3397\/15\/12\/370\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T18:52:09Z","timestamp":1760208729000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1660-3397\/15\/12\/370"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12,1]]},"references-count":37,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2017,12]]}},"alternative-id":["md15120370"],"URL":"https:\/\/doi.org\/10.3390\/md15120370","relation":{},"ISSN":["1660-3397"],"issn-type":[{"value":"1660-3397","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12,1]]}}}